BRIEF published on 09/10/2025 at 08:40, 9 months 17 days ago Swixx BioPharma et Lundbeck forment un partenariat multirégional pour le SNC Marchés Émergents Swixx BioPharma Investissements Dans Les Soins De Santé Lundbeck Partenariat CNS
PRESS RELEASE published on 09/10/2025 at 08:35, 9 months 17 days ago HBM Portfolio Company Swixx BioPharma and Lundbeck Sign Multi-Regional CNS Partnership HBM Healthcare Investments announces partnership between Swixx BioPharma, Lundbeck for CNS therapies in South-East Europe, Turkey and Latin America Partnership HBM Healthcare Investments CNS Therapies Swixx BioPharma Lundbeck
BRIEF published on 09/01/2025 at 17:52, 9 months 26 days ago HBM Healthcare Investments AG publie ses chiffres clés d'août 2025 Performance NAV Cours De L'action Bourse Suisse HBM Santé
BRIEF published on 09/01/2025 at 17:52, 9 months 26 days ago HBM Healthcare Investments AG Reports August 2025 Key Figures Performance Share Price NAV Swiss Exchange HBM Healthcare
PRESS RELEASE published on 09/01/2025 at 17:47, 9 months 26 days ago Key Figures 31.08.2025 HBM Healthcare Investments AG reports key financial figures for August 2025, with a NAV of 240.62 CHF and Total Net Assets of 1,610 million CHF. Share price increased by 4.0% HBM Healthcare Investments Financial Figures Share Price NAV August 2025
BRIEF published on 08/18/2025 at 17:52, 10 months 9 days ago HBM Healthcare Investments AG Reports August 2025 Key Figures Financial Performance Net Asset Value Share Price HBM Healthcare August 2025
BRIEF published on 08/18/2025 at 17:52, 10 months 9 days ago HBM Healthcare Investments AG publie ses chiffres clés d'août 2025 Performance Financière Cours De L'action HBM Santé Valeur Nette D'inventaire Août 2025
PRESS RELEASE published on 08/18/2025 at 17:47, 10 months 9 days ago Key Figures 15.08.2025 HBM Healthcare Investments AG reports key figures for August 15, 2025, showing performance in CHF with NAV at 240.16 and share price at 175.60 Performance HBM Healthcare Investments AG Key Figures CHF August 15 2025
BRIEF published on 08/04/2025 at 17:51, 10 months 23 days ago HBM Healthcare Investments publie ses chiffres clés pour juillet 2025 Performance Financière Cours De L'action HBM Santé Valeur Nette D'inventaire Volatilité Des Investissements
BRIEF published on 08/04/2025 at 17:51, 10 months 23 days ago HBM Healthcare Investments Declares July 2025 Key Figures Financial Performance Net Asset Value Share Price HBM Healthcare Investment Volatility
Published on 06/27/2026 at 16:50, 9 hours 52 minutes ago Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
Published on 06/27/2026 at 01:40, 1 day 1 hour ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 1 day 2 hours ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 1 day 3 hours ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 1 day 3 hours ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/27/2026 at 00:05, 1 day 2 hours ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 1 day 2 hours ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 1 day 3 hours ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 1 day 3 hours ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 1 day 3 hours ago EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
